Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
|
|
| 412.60 Delayed Data As of 12:22pm ET |  +8.48 / +2.10%Today’s Change | 329.09 Today|||52-Week Range 592.59 | -24.00% Year-to-Date |
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Yancopoulos George Damis |  Sale | 10/30/2015 | 92,316 | $559.08 | $51.6M | -27.50% |
Vagelos P Roy Chairman | Sale | 5/12/2016 | 112,020 | $368.70 | $41.3M | +10.52% |
Stahl Neil Executive Vice President-Research & Development | Sale | 11/05/2015 | 39,605 | $567.63 | $22.5M | -28.37% |
Sanofi |  Buy | 2/16/2016 | 33,131 | $391.36 | $13.0M | +3.15% |
Sanofi | Buy | 2/17/2016 | 27,088 | $391.85 | $10.6M | +1.73% |
Vagelos P Roy Chairman | Sale | 11/02/2015 | 13,257 | $580.18 | $7.7M | -30.20% |
Stahl Neil Executive Vice President-Research & Development | Sale | 11/05/2015 | 13,312 | $567.63 | $7.6M | -28.37% |
Sanofi | Buy | 6/14/2016 | 19,708 | $362.15 | $7.1M | +10.27% |
Sanofi | Buy | 1/12/2016 | 14,169 | $469.71 | $6.7M | -14.92% |
Sanofi | Buy | 6/14/2016 | 16,935 | $365.21 | $6.2M | +10.27% |
